Sartorius Aktiengesellschaft (VIE:SATG)
Austria · Delayed Price · Currency is EUR 171.00
-1.60 (-0.93%)
At close: Sep 23, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Bioprocess Solutions | 2.69B | Log In | Log In | Log In | Log In | Upgrade |
Bioprocess Solutions Growth | 4.93% | Log In | Log In | Log In | Log In | Upgrade |
Lab Products & Services | 690.50M | Log In | Log In | Log In | Log In | Upgrade |
Lab Products & Services Growth | -0.63% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Bioprocess Solutions Underlying EBITDA | 787.20M | Log In | Log In | Log In | Log In | Upgrade |
Bioprocess Solutions Underlying EBITDA Growth | 12.53% | Log In | Log In | Log In | Log In | Upgrade |
Lab Products & Services Underlying EBITDA | 158.10M | Log In | Log In | Log In | Log In | Upgrade |
Lab Products & Services Underlying EBITDA Growth | -6.73% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
EMEA | 1.39B | Log In | Log In | Log In | Log In | Upgrade |
EMEA Growth | 6.88% | Log In | Log In | Log In | Log In | Upgrade |
Americas | 1.20B | Log In | Log In | Log In | Log In | Upgrade |
Americas Growth | -0.15% | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific | 792.30M | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific Growth | 4.83% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Bioprocess Solutions Order Intake | 2.69B | Log In | Log In | Log In | Log In | Upgrade |
Bioprocess Solutions Order Intake Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Lab Products & Services Order Intake | 684.40M | Log In | Log In | Log In | Log In | Upgrade |
Lab Products & Services Order Intake Growth | - | Log In | Log In | Log In | Log In | Upgrade |